Financial Performance - Total revenue for Q1 2021 reached RMB 552.79 million, a 61.17% increase compared to RMB 342.99 million in the same period last year[10] - Net profit attributable to shareholders was RMB 21.80 million, representing a 151.21% increase from RMB 8.68 million year-on-year[5] - Operating cash flow net amount was RMB 53.02 million, a significant increase of 255.71% compared to RMB 14.90 million in the previous year[10] - The weighted average return on net assets increased to 0.93%, up 181.82% from 0.33% in the previous year[5] Investment and Expenses - Research and development expenses surged by 391.16% to RMB 9.55 million, reflecting the company's increased investment in R&D[10] - The company’s sales expenses increased by 105.29% to RMB 247.87 million, driven by higher sales revenue[10] Assets and Liabilities - Total assets at the end of the reporting period were RMB 3.16 billion, up 2.14% from RMB 3.10 billion at the end of the previous year[5] - The company reported a significant increase in accounts receivable, which rose by 121.60% to RMB 53.94 million due to increased revenue and bank acceptance bill collections[9] Shareholder Information - The number of shareholders at the end of the reporting period was 42,952, indicating a stable shareholder base[6] - The company has no overdue commitments or significant changes in expected cumulative net profit for the year[10]
神奇制药(600613) - 2021 Q1 - 季度财报